Home/Filings/4/0001415889-24-001329
4//SEC Filing

Norkunas Matthew 4

Accession 0001415889-24-001329

CIK 0001733294other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 5:00 PM ET

Size

19.3 KB

Accession

0001415889-24-001329

Insider Transaction Report

Form 4
Period: 2024-01-15
Norkunas Matthew
CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2024-01-15$1.91/sh2,577$4,92244,792 total
  • Tax Payment

    Common Stock

    2024-01-15$1.91/sh2,320$4,43149,166 total
  • Tax Payment

    Common Stock

    2024-01-15$1.91/sh581$1,11050,259 total
  • Exercise/Conversion

    Common Stock

    2024-01-15+6,69451,486 total
  • Exercise/Conversion

    Common Stock

    2024-01-15+1,67450,840 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-151,6746,692 total
    Common Stock (1,674 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-15+7,43747,369 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-157,4370 total
    Common Stock (7,437 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-156,69420,081 total
    Common Stock (6,694 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
  • [F3]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
  • [F4]On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001816836

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 5:00 PM ET
Size
19.3 KB